Type i interferons protect from toll-like receptor 9associated liver injury and regulate IL-1 receptor antagonist in mice

Gastroenterology

Volumn 140, Issue 2, 2011, Pages 697-708.e4

  Petrasek, Jan ^a   Dolganiuc, Angela ^a   Csak, Timea ^a   Kurtjones, Evelyn A ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Bacterial DNA; Immunology; Innate Immunity; Liver Disease

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; PEGINTERFERON ALPHA2B; RECOMBINANT INTERFERON; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; DRUG EFFECT; IN VIVO STUDY; INFLAMMATION; LIVER CELL; LIVER INJURY; LIVER PROTECTION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SINGLE DRUG DOSE; UPREGULATION; WILD TYPE;

EID: 79251600358     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.08.020     Document Type: Article

References (37)

1. A.M. Minino, M.P. Heron, and S.L. Murphy Deaths: final data for 2004 Natl Vital Stat Rep 55 2007 1 119
2. J. Polson, and W.M. Lee AASLD position paper: the management of acute liver failure Hepatology 41 2005 1179 1197
3. E. Seki, and D.A. Brenner Toll-like receptors and adaptor molecules in liver disease: update Hepatology 48 2008 322 335
4. S. Huck, E. Deveaud, and A. Namane Abnormal DNA methylation and deoxycytosine-deoxyguanine content in nucleosomes from lymphocytes undergoing apoptosis FASEB J 13 1999 1415 1422
5. T. Gustot, A. Lemmers, and C. Moreno Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver Hepatology 43 2006 989 1000
6. Y. Moritoki, Z.X. Lian, and H. Wulff AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers Hepatology 45 2007 314 322
7. A. Karrar, U. Broome, and T. Sodergren Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis Gastroenterology 132 2007 1504 1514
8. A.B. Imaeda, A. Watanabe, and M.A. Sohail Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome J Clin Invest 119 2009 305 314
9. M.K. Connolly, A.S. Bedrosian, and J. Mallen-St Clair In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha J Clin Invest 119 2009 3213 3225
10. A. Watanabe, A. Hashmi, and D.A. Gomes Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via Toll-like receptor 9 Hepatology 46 2007 1509 1518
11. A. Mencin, J. Kluwe, and R.F. Schwabe Toll-like receptors as targets in chronic liver diseases Gut 58 2009 704 720
12. S. Tsuchihashi, Y. Zhai, and Q. Bo Heme oxygenase-1 mediated cytoprotection against liver ischemia and reperfusion injury: inhibition of type-1 interferon signaling Transplantation 83 2007 1628 1634
13. L.L. Ma, X. Gao, and L. Liu CpG oligodeoxynucleotide triggers the liver inflammatory reaction and abrogates spontaneous tolerance Liver Transpl 15 2009 915 923
14. K.S. Lee, C.A. Scanga, and E.M. Bachelder TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae Cell Immunol 245 2007 103 110
15. L. Romics Jr., A. Dolganiuc, and A. Velayudham Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni-bacterium acnes J Leukoc Biol 78 2005 1255 1264
16. A. Velayudham, I. Hritz, and A. Dolganiuc Critical role of Toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury J Hepatol 45 2006 813 824
17. T. Kawai, and S. Akira TLR signaling Semin Immunol 19 2007 24 32
18. P.N. Moynagh TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway Trends Immunol 26 2005 469 476
19. I. Hritz, P. Mandrekar, and A. Velayudham The critical role of Toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88 Hepatology 48 2008 1224 1231
20. Y. Zhai, B. Qiao, and F. Gao Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion Hepatology 47 2008 199 206
21. R. Lim, B. Knight, and K. Patel Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo Hepatology 43 2006 1074 1083
22. K. Honda, H. Yanai, and H. Negishi IRF-7 is the master regulator of type-I interferon-dependent immune responses Nature 434 2005 772 777
23. S.L. Schafer, R. Lin, and P.A. Moore Regulation of type I interferon gene expression by interferon regulatory factor-3 J Biol Chem 273 1998 2714 2720
24. M. Sato, N. Hata, and M. Asagiri Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7 FEBS Lett 441 1998 106 110
25. M. Itakura, A. Tokuda, and H. Kimura Blockade of secondary lymphoid tissue chemokine exacerbates Propionibacterium acnes-induced acute lung inflammation J Immunol 166 2001 2071 2079
26. C.A. Dinarello Immunological and inflammatory functions of the interleukin-1 family Annu Rev Immunol 27 2009 519 550
27. B.D. Cosgrove, C. Cheng, and J.R. Pritchard An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor-alpha Hepatology 48 2008 276 288
28. E.N. Benveniste, and H. Qin Type I interferons as anti-inflammatory mediators Sci STKE 2007 2007 pe70
29. K. Honda, Y. Ohba, and H. Yanai Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction Nature 434 2005 1035 1040
30. H. Yoneyama, K. Matsuno, and Y. Zhang Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease J Exp Med 193 2001 35 49
31. Y.J. Liu IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors Annu Rev Immunol 23 2005 275 306
32. H. Yoneyama, S. Narumi, and Y. Zhang Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes J Exp Med 195 2002 1257 1266
33. Z. Wang, M. Wang, and B.I. Carr The inhibitory effect of interleukin 1beta on rat hepatocyte DNA synthesis is mediated by nitric oxide Hepatology 28 1998 430 435
34. L. Wan, C.W. Lin, and Y.J. Lin Type I IFN induced IL1-Ra expression in hepatocytes is mediated by activating STAT6 through the formation of STAT2: STAT6 heterodimer J Cell Mol Med 12 2008 876 888
35. S. Naveau, D. Emilie, and E. Borotto Interleukin-1 receptor antagonist plasma concentration is specifically increased by alpha-2A-interferon treatment J Hepatol 27 1997 272 275
36. H. Iizasa, H. Yoneyama, and N. Mukaida Exacerbation of granuloma formation in IL-1 receptor antagonist-deficient mice with impaired dendritic cell maturation associated with Th2 cytokine production J Immunol 174 2005 3273 3280
37. M. Shinoda, A.W. Tilles, and N. Kobayashi A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats J Surg Res 137 2007 130 140